Skip to main content
. 2017 May 7;8(30):49351–49358. doi: 10.18632/oncotarget.17656

Figure 1.

Figure 1

(A) BRAF-RAS multiplex amplification gel (B) RET multiplex amplification gel (2% agarose gel in 1X TBE).